Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer.

被引：0
|
作者：
Nutting, Christopher
Rooney, Keith
Foran, Bernadette
Pettit, Laura
Beasley, Matthew
Finneran, Laura
Roe, Justin
Tyler, Justine
Roques, Tom
Cook, Audrey
Petkar, Imran
Bhide, Shree
Srinivasan, Devraj
Boon, Cheng
De Winton, Emma
Frogley, Robert
Mertens, Kathrin
Emson, Marie
Hall, Emma
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Belfast City Hosp, Belfast, Antrim, North Ireland
[3] Weston Pk Hosp, Sheffield, S Yorkshire, England
[4] Royal Shrewsbury Hosp, Shrewsbury, Salop, England
[5] Bristol Haematol & Oncol Ctr, Bristol, Avon, England
[6] Inst Canc Res, London, England
[7] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[8] Cheltenham Gen Hosp, Cheltenham, Glos, England
[9] Guys & St Thomas NHS Fdn Trust, London, England
[10] Royal Marsden Hosp, London, England
[11] Western Gen, Edinburgh, Midlothian, Scotland
[12] Worcestershire Royal Hosp, Worcester, MA USA
[13] Royal United Hosp, Bath, Avon, England
[14] Boehringer Ingelheim GmbH & Co KG, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6508
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Quality of life and two-year results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (DO-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer.
    Nutting, Christopher
    Rooney, Keith
    Foran, Bernadette
    Pettit, Laura
    Beasley, Matthew
    Finneran, Laura
    Roe, Justin
    Tyler, Justine
    Roques, Tom
    Cook, Audrey
    Petkar, Imran
    Bhide, Shree
    Srinivasan, Devraj
    Boon, Cheng
    De Winton, Emma
    Frogley, Robert
    Sydenham, Mark Adrian
    Emson, Marie
    Hall, Emma
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] DARS: a phase III randomised multicentre study of dysphagia- optimised intensity-modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer
    Petkar, Imran
    Rooney, Keith
    Roe, Justin W. G.
    Patterson, Joanne M.
    Bernstein, David
    Tyler, Justine M.
    Emson, Marie A.
    Morden, James P.
    Mertens, Kathrin
    Miles, Elizabeth
    Beasley, Matthew
    Roques, Tom
    Bhide, Shreerang A.
    Newbold, Kate L.
    Harringtonl, Kevin J.
    Hall, Emma
    Nutting, Christopher M.
    BMC CANCER, 2016, 16
  • [3] DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer
    Imran Petkar
    Keith Rooney
    Justin W. G. Roe
    Joanne M. Patterson
    David Bernstein
    Justine M. Tyler
    Marie A. Emson
    James P. Morden
    Kathrin Mertens
    Elizabeth Miles
    Matthew Beasley
    Tom Roques
    Shreerang A. Bhide
    Kate L. Newbold
    Kevin J. Harrington
    Emma Hall
    Christopher M. Nutting
    BMC Cancer, 16
  • [4] Results of DARS: a randomised phase III trial of dysphagia-optimised intensity modulated radiotherapy (DO-IMRT) versus standard IMRT (S-IMRT) in oropharyngeal (OPC) and hypopharyngeal (HPC) cancer
    Nutting, Chris
    Rooney, Keith
    Foran, Bernie
    Pettit, Laura
    Beasley, Matthew
    Finneran, Laura
    Roe, Justin
    Tyler, Justine
    Petkar, Imran
    Bhide, Shree
    Frogley, Robert
    Sydenham, Mark
    Emson, Marie
    Hall, Emma
    ORAL ONCOLOGY, 2021, 118
  • [5] Results of ARTIX phase III study: adaptive radiotherapy versus standard IMRT in head and neck cancer
    Castelli, J.
    Benezery, K.
    Hasbini, A.
    Gery, B.
    Berger, A.
    Liem, X.
    Guihard, S.
    Chapet, S.
    Thureau, S.
    Auberdiac, P.
    Pommier, P.
    Thariat, J.
    Campillo, B.
    de Crevoisier, R.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S749 - S750
  • [6] Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT)
    Evangelia Peponi
    Christoph Glanzmann
    Bettina Willi
    Gerhard Huber
    Gabriela Studer
    Radiation Oncology, 6
  • [7] Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT)
    Peponi, Evangelia
    Glanzmann, Christoph
    Willi, Bettina
    Huber, Gerhard
    Studer, Gabriela
    RADIATION ONCOLOGY, 2011, 6
  • [8] INTENSITY MODULATED RADIOTHERAPY (IMRT) IN PATIENTS WITH HEAD AND NECK CANCER
    Van den Weyngaert, D.
    Van Gestel, D.
    Dom, B.
    Schrijvers, D.
    Vermorken, J. B.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S258 - S258
  • [9] IS INTENSITY MODULATED RADIOTHERAPY (IMRT) THE IDEAL TECHNIQUE FOR HEAD AND NECK CANCER?
    Pedro Olive, A.
    Lainez Baquero, C.
    Vila Capel, A.
    Sanchez-Reyes Fernandez, A.
    Artola Codina, N.
    Moya Cascan, L. M.
    Julia Sanhuja, J. C.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S322 - S322
  • [10] Phase I study of panitumumab, chemotherapy and intensity-modulated radiotherapy (IMRT) for head and neck cancer (HNC): Early results
    Wirth, L. J.
    Posner, M. R.
    TIshler, R. B.
    Haddad, R. I.
    Goguen, L.
    Clark, J. R.
    Allen, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345